Contiflo OD 0.4mg Capsule ER
Contiflo OD 0.4mg Capsule ER is an alpha-adrenergic antagonist that is used in the treatment of benign prostatic hyperplasia. It helps to relieve symptoms like difficulty in passing urine. However, it does not decrease the size of the prostate.
Contiflo OD 0.4mg Capsule ER
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Contiflo OD 0.4mg Capsule ER is an alpha-adrenergic antagonist that is used in the treatment of benign prostatic hyperplasia. It helps to relieve symptoms like difficulty in passing urine. However, it does not decrease the size of the prostate.
Contiflo OD 0.4mg Capsule ER is an alpha-adrenergic antagonist that is used in the treatment of benign prostatic hyperplasia. It helps to relieve symptoms like difficulty in passing urine. However, it does not decrease the size of the prostate.
Contiflo OD 0.4mg Capsule ER is advised to take it in a dose and duration as per prescription. It may be taken with or without food, but take at the same time regularly. Swallow the medicine as a whole without crushing or chewing it. You should not stop taking the medicine without consulting the doctor as it may lead to the worsening of your symptoms. The course of the treatment should be completed for better efficacy of the medicine.
Use of this medicine can cause some common side effects such as dizziness, backe pain, chest pain, ejaculation disorder, and retrograde ejaculation. If any of the side effects persist or bother you, you must consult the doctor without delay.
Simple lifestyle changes can help you manage your symptoms better. Try to urinate as soon as you feel the urge, however, never strain or push to empty your bladder. You should avoid drinking caffeinated or alcoholic drinks at night and a few hours before going to bed or going out.
Before receiving the treatment, inform your doctor if you are on any medication for any other health condition. If you have to undergo eye surgery due to cataracts or glaucoma then inform your eye doctor about the usage of this medicine. Patients with liver disease must be cautious while receiving the prescription, and they must receive regular follow-ups as per the doctor’s advice.
03Uses
Treatment of Benign prostatic hyperplasia
04How To Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Contiflo OD 0.4mg Capsule ER may be taken with or without food, but it is better to take it at a fixed time.
05How It Works
Contiflo OD 0.4mg Capsule ER is an alpha blocker. It works by relaxing the muscles around the bladder exit and prostate gland so urine is passed more easily. This helps empty the bladder completely and reduces the need to pass urine frequently or urgently in BPH.
06What If You Miss A Dose?
Q: What if you forget to take Contiflo OD Capsule ER?
A: If you miss a dose of Contiflo OD 0.4mg Capsule ER, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
07Benefits
In Treatment of Benign prostatic hyperplasia
When your prostate gland becomes enlarged it can cause urinary problems such as difficulty passing urine and a need to go to the toilet frequently or urgently. It can also cause urine flow to be slower. If not treated, there is a risk that your urine flow will be completely blocked. Contiflo OD 0.4mg Capsule ER works by relaxing muscles in the bladder and prostate. So, it can rapidly relieve the symptoms and make it easier for you to urinate. However, it may take up to 6 months to notice the full benefit. Take this medicine exactly as prescribed for maximum benefits.
08Side Effects
Chest pain
Inflammation of the nose
Dizziness
Ejaculation disorder
Headache
Abdominal pain
Back pain
Nausea
Infection
09Safety Information
Alcohol:UNSAFE
Contiflo OD 0.4mg Capsule ER may cause excessive drowsiness with alcohol.
Pregnancy:CONSULT YOUR DOCTOR
Information regarding the use of Contiflo OD 0.4mg Capsule ER during pregnancy is not available. Please consult your doctor.
Breast feeding:CONSULT YOUR DOCTOR
Contiflo OD 0.4mg Capsule ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.Contiflo OD 0.4mg Capsule ER is not indicated for use in women.
Driving:SAFE
Contiflo OD 0.4mg Capsule ER does not usually affect your ability to drive.
Kidney:SAFE IF PRESCRIBED
Contiflo OD 0.4mg Capsule ER is safe to use in patients with kidney disease. No dose adjustment of Contiflo OD 0.4mg Capsule ER is recommended.However, limited information is available on the use of Contiflo OD 0.4mg Capsule ER in patients with end stage kidney disease. Please consult your doctor.
Liver:CAUTION
Contiflo OD 0.4mg Capsule ER should be used with caution in patients with severe liver disease. Dose adjustment of Contiflo OD 0.4mg Capsule ER may be needed. Please consult your doctor.
10Drug Tips
Contiflo OD 0.4mg Capsule ER helps in relieving the symptoms of enlarged prostate. It does not decrease the size of the prostate.
Contiflo OD 0.4mg Capsule ER must be taken with food.
You will feel better within hours or days of starting the treatment. Full effect is usually seen within 2 weeks.
Contiflo OD 0.4mg Capsule ER may cause dizziness or sleepiness. Do not drive or do anything requiring concentration until you know how it affects you.
If you are scheduled to undergo an eye surgery due to cataract or glaucoma, inform your eye doctor about the usage of Contiflo OD 0.4mg Capsule ER.
Inform your doctor if you have ever been diagnosed with kidney or liver problems.
References
Sources and references
Westfall TC, WestfallIn DP. Adrenergic Agonists and Antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 307.
Robertson D, Biaggioni I. Adrenoreceptor Antagonists Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 153.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1314.
Tamsulosin. Guildford, Surrey: Zentiva; 2017 [revised 29 Aug. 2018]. [Accessed 04 Apr. 2019] (online) Available from: View
Tamsulosin.Tokyo, Japan: Astellas, Pharma Inc; 2005. [Accessed 04 Apr. 2019] (online) Available from: View
Central Drugs Standard Control Organisation (CDSCO). Tamsulosin hydrochloride. [Accessed 04 Apr. 2019] (online) Available from: View
